Literature DB >> 7338575

Interaction studies with bumetanide and furosemide. Effects of probenecid and of indomethacin on response to bumetanide in man.

D C Brater, W R Fox, P Chennavasin.   

Abstract

Bumetanide was administered intravenously in doses of 0.5 and 1.0 mg to eight normal subjects with and without pretreatment with probenecid or indomethacin. Probenecid did not affect either the cumulative response or the time course of response to bumetanide. This may mean that probenecid and potentially other exogenous or endogenous organic acids do not affect the renal handling of bumetanide in normal man. Indomethacin pretreatment decreased the cumulative 4-hour excretion of sodium caused by 1.0 mg bumetanide from 276 +/- 22.9 to 202 +/- 20.9 mEq (P less than 0.003). Effects on volume and chloride paralleled those of sodium, while potassium excretion was not affected. When the response was analyzed as increment in fractional excretion over basal solute excretion, determined from separate control studies, indomethacin still decreased the response, possibly indicating that endogenous prostaglandins may play a role in determining the overall response to bumetanide.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7338575     DOI: 10.1002/j.1552-4604.1981.tb05677.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  5 in total

1.  Non-steroidal anti-inflammatory drugs and the kidney.

Authors:  M L Orme
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-21

2.  Repeat prescribing of non-steroidal anti-inflammatory drugs excluding aspirin: how careful are we?

Authors:  K Steele; K A Mills; A E Gilliland; W G Irwin; A Taggart
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-17

Review 3.  Aspirin, paracetamol and non-steroidal anti-inflammatory drugs. A comparative review of side effects.

Authors:  P D Fowler
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

Review 4.  Diuretic drugs. Progress in clinical pharmacology.

Authors:  A Lant
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 5.  Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  A Ward; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.